Comparison of pediatric and adult antibiotic-associated diarrhea and Clostridium difficile infections.
暂无分享,去创建一个
[1] M. Delgado-Rodríguez,et al. Systematic review and meta-analysis. , 2017, Medicina intensiva.
[2] S. Mahant,et al. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. , 2015, The Cochrane database of systematic reviews.
[3] H. Szajewska,et al. Systematic review with meta‐analysis: Lactobacillus rhamnosus GG in the prevention of antibiotic‐associated diarrhoea in children and adults , 2015, Alimentary pharmacology & therapeutics.
[4] A. Simon,et al. Epidemiology of Clostridium difficile in Germany based on a single center long-term surveillance and German-wide genotyping of recent isolates provided to the advisory laboratory for diagnostic reasons. , 2015, International journal of medical microbiology : IJMM.
[5] Scott W. Mitchell,et al. Fecal microbiota transplantation in gastrointestinal disease: 2015 update and the road ahead , 2015, Expert review of gastroenterology & hepatology.
[6] H. Szajewska,et al. Systematic review with meta‐analysis: Saccharomyces boulardii supplementation and eradication of Helicobacter pylori infection , 2015, Alimentary pharmacology & therapeutics.
[7] E. Goldstein,et al. Clostridium difficile Infection in Long-term Care Facilities: A Call to Action for Antimicrobial Stewardship. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[8] W. Trick,et al. Pathway to Prevention of Nosocomial Clostridium difficile Infection. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[9] Nasia Safdar,et al. Current Trends in the Epidemiology and Outcomes of Clostridium difficile Infection. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[10] L. Mcfarland. From yaks to yogurt: the history, development, and current use of probiotics. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[11] A. Gasbarrini,et al. Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection , 2015, Alimentary pharmacology & therapeutics.
[12] P. Patel,et al. Outbreak of Clostridium difficile Infections at an Outpatient Hemodialysis Facility—Michigan, 2012–2013 , 2015, Infection Control & Hospital Epidemiology.
[13] L. Mcfarland. Probiotics for the Primary and Secondary Prevention of C. difficile Infections: A Meta-analysis and Systematic Review , 2015, Antibiotics.
[14] S. Vermeersch,et al. Prevalence and management of antibiotic associated diarrhea in general hospitals , 2015, BMC Infectious Diseases.
[15] M. Cooper,et al. Clostridium difficile Drug Pipeline: Challenges in Discovery and Development of New Agents , 2015, Journal of medicinal chemistry.
[16] M. Olsen,et al. The morbidity, mortality, and costs associated with Clostridium difficile infection. , 2015, Infectious disease clinics of North America.
[17] Qinqin Li,et al. Probiotics for the prevention of antibiotic-associated diarrhoea in older patients: a systematic review. , 2015, Travel medicine and infectious disease.
[18] C. Knoderer,et al. Acid-Suppressing Agents and Risk for Clostridium difficile Infection in Pediatric Patients , 2015, Clinical pediatrics.
[19] D. Gerding,et al. Molecular Epidemiology of Clostridium difficile Infections in Children: A Retrospective Cohort Study , 2015, Infection Control & Hospital Epidemiology.
[20] R. Eri,et al. Can probiotic yogurt prevent diarrhoea in children on antibiotics? A double-blind, randomised, placebo-controlled study , 2015, BMJ Open.
[21] S. Hendren,et al. Postoperative Burden of Hospital-Acquired Clostridium difficile Infection , 2015, Infection Control & Hospital Epidemiology.
[22] K. Edwards,et al. Novel Risk Factors for Recurrent Clostridium difficile Infection in Children , 2015, Journal of pediatric gastroenterology and nutrition.
[23] P. Schreckenberger,et al. Clostridium difficileInfection (CDI) Severity and Outcome among Patients Infected with the NAP1/BI/027 Strain in a Non-Epidemic Setting , 2014, Infection Control & Hospital Epidemiology.
[24] Yong Jo Kim,et al. Clinical Characteristics of Symptomatic Clostridium difficile Infection in Children: Conditions as Infection Risks and Whether Probiotics Is Effective , 2014, Pediatric gastroenterology, hepatology & nutrition.
[25] A. Weintraub,et al. Risk factors of Clostridium difficile infections among patients in a university hospital in Shanghai, China. , 2014, Anaerobe.
[26] C. Dietrich,et al. Commercially available probiotic drinks containing Lactobacillus casei DN-114001 reduce antibiotic-associated diarrhea. , 2014, World journal of gastroenterology.
[27] Gregory H Gorman,et al. Association of Clostridium difficile infections with acid suppression medications in children. , 2014, The Journal of pediatrics.
[28] C. Lübbert,et al. Clostridium difficile infection: guideline-based diagnosis and treatment. , 2014, Deutsches Arzteblatt international.
[29] C. Hollenbeak,et al. Attributable Inpatient Costs of Recurrent Clostridium difficile Infections , 2014, Infection Control & Hospital Epidemiology.
[30] A. Kara,et al. Saccharomyces boulardii CNCM I-745 in different clinical conditions , 2014, Expert opinion on biological therapy.
[31] H. Dupont,et al. A Hospital-based Study of the Clinical Characteristics of Clostridium difficile Infection in Children , 2014, The Pediatric infectious disease journal.
[32] F. Friedmacher,et al. The impact of Clostridium difficile on paediatric surgical practice: a systematic review , 2014, Pediatric Surgery International.
[33] V. Andreasen,et al. The incidence and clinical symptomatology of Clostridium difficile infections in a community setting in a cohort of Danish patients attending general practice , 2014, European Journal of Clinical Microbiology & Infectious Diseases.
[34] D. Gerding,et al. NAP1 strain type predicts outcomes from Clostridium difficile infection. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[35] S. Roberts,et al. Clostridium difficile as a cause of healthcare-associated diarrhoea among children in Auckland, New Zealand: clinical and molecular epidemiology , 2014, European Journal of Clinical Microbiology & Infectious Diseases.
[36] Jihyun Cho,et al. Reduction in the incidence of hospital-acquired Clostridium difficile infection through infection control interventions other than the restriction of antimicrobial use. , 2014, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[37] S. Hutfless,et al. The Prevalence of Clostridium difficile Infection in Pediatric and Adult Patients with Inflammatory Bowel Disease , 2014, Digestive Diseases and Sciences.
[38] T. Riley,et al. Clostridium difficile infection diagnosis in a paediatric population: comparison of methodologies , 2014, European Journal of Clinical Microbiology & Infectious Diseases.
[39] J. Meek,et al. Clostridium difficile Infection Among Children Across Diverse US Geographic Locations , 2014, Pediatrics.
[40] R. L. Berger,et al. Fulminant Clostridium difficile colitis: Prospective development of a risk scoring system , 2014, The journal of trauma and acute care surgery.
[41] D. Gerding,et al. Recurrence of Clostridium difficile infection among veterans with spinal cord injury and disorder. , 2014, American Journal of Infection Control.
[42] R. Bush,et al. Predictors of Clostridium difficile infections in hospitalized children. , 2014, Journal of hospital medicine.
[43] M. Mulvey,et al. Severe clinical outcome is uncommon in Clostridium difficile infection in children: a retrospective cohort study , 2014, BMC Pediatrics.
[44] L. Miller,et al. Probiotics reduce symptoms of antibiotic use in a hospital setting: a randomized dose response study. , 2014, Vaccine.
[45] P. Donnan,et al. Community-associated Clostridium difficile infection among older people in Tayside, Scotland, is associated with antibiotic exposure and care home residence: cohort study with nested case-control. , 2013, The Journal of antimicrobial chemotherapy.
[46] Fei Liu,et al. Prevention and treatment of diarrhoea with Saccharomyces boulardii in children with acute lower respiratory tract infections. , 2013, Beneficial microbes.
[47] N. Khanafer,et al. Predictors of Clostridium difficile infection severity in patients hospitalised in medical intensive care. , 2013, World journal of gastroenterology.
[48] L. Mcfarland,et al. Preventing pediatric antibiotic-associated diarrhea and Clostridium difficile infections with probiotics: A meta-analysis , 2013 .
[49] D. Ford,et al. Possible Association between Obesity and Clostridium difficile Infection , 2013, Emerging infectious diseases.
[50] Alessio Pigazzi,et al. Clostridium difficile colitis in the United States: a decade of trends, outcomes, risk factors for colectomy, and mortality after colectomy. , 2013, Journal of the American College of Surgeons.
[51] Jocelyn A. Srigley,et al. Inappropriate use of antibiotics and Clostridium difficile infection. , 2013, American journal of infection control.
[52] Ankur Segon,et al. Epidemiology of Clostridium difficile-Associated Disease (CDAD): A Shift from Hospital-Acquired Infection to Long-Term Care Facility-Based Infection , 2013, Digestive Diseases and Sciences.
[53] Michael P. Anderson,et al. Clostridium difficile Infection in the Hospitalized Pediatric Population: Increasing Trend in Disease Incidence , 2013, The Pediatric infectious disease journal.
[54] P. Tamma,et al. Distinguishing community-associated from hospital-associated Clostridium difficile infections in children: implications for public health surveillance. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[55] K. Garey,et al. Assessment of treatment patterns and patient outcomes before vs after implementation of a severity-based Clostridium difficile infection treatment policy. , 2013, The Journal of hospital infection.
[56] A. Troxel,et al. Trends in Clostridium difficile infection and risk factors for hospital acquisition of Clostridium difficile among children with cancer. , 2013, The Journal of pediatrics.
[57] S. Coffin,et al. Clostridium difficile infection is associated with increased risk of death and prolonged hospitalization in children. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[58] N. Haslam,et al. Probiotic VSL#3 prevents antibiotic-associated diarrhoea in a double-blind, randomized, placebo-controlled clinical trial. , 2013, The Journal of hospital infection.
[59] V. Palda,et al. Probiotics for the prevention of antibiotic-associated diarrhea and Clostridium difficile infection among hospitalized patients: systematic review and meta-analysis , 2013, Open medicine : a peer-reviewed, independent, open-access journal.
[60] A. Zinsmeister,et al. The epidemiology of Clostridium difficile infection in children: a population-based study. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[61] K.,et al. Attributable Burden of Hospital-Onset Clostridium difficile Infection: A Propensity Score Matching Study , 2013, Infection Control & Hospital Epidemiology.
[62] Robin Patel,et al. Asymptomatic Clostridium difficile colonization in a tertiary care hospital: admission prevalence and risk factors. , 2013, American journal of infection control.
[63] Ashwin N Ananthakrishnan,et al. Guidelines for Diagnosis, Treatment, and Prevention of Clostridium difficile Infections , 2013, The American Journal of Gastroenterology.
[64] Elena Deych,et al. Markers of intestinal inflammation, not bacterial burden, correlate with clinical outcomes in Clostridium difficile infection. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[65] A. Localio,et al. Risks and Benefits Associated With Antibiotic Use for Acute Respiratory Infections: A Cohort Study , 2013, The Annals of Family Medicine.
[66] P. Toltzis,et al. Recent trends in the epidemiology and treatment of C. difficile infection in children , 2013, Current opinion in pediatrics.
[67] M. Shoaran,et al. Probiotics for the Treatment of Pediatric Helicobacter Pylori Infection: A Randomized Double Blind Clinical Trial , 2013, Iranian Journal of Pediatrics.
[68] E. Zoetendal,et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. , 2013, The New England journal of medicine.
[69] D. Enoch,et al. Five Years Experience of Clostridium difficile Infection in Children at a UK Tertiary Hospital: Proposed Criteria for Diagnosis and Management , 2012, PloS one.
[70] A. Le Monnier,et al. Clostridium difficile carriage in healthy infants in the community: a potential reservoir for pathogenic strains. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[71] W. Trick,et al. Is primary prevention of Clostridium difficile infection possible with specific probiotics? , 2012, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[72] M. Falagas,et al. Risk factors for development of Clostridium difficile infection due to BI/NAP1/027 strain: a meta-analysis. , 2012, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[73] Carolyn M Hutter,et al. Diarrhea etiology in a pediatric emergency department: a case control study. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[74] S. Chuang,et al. Clostridium difficile infection outbreak in a male rehabilitation ward, Hong Kong Special Administrative Region (China), 2011. , 2012, Western Pacific surveillance and response journal : WPSAR.
[75] C. Cortina,et al. Simultaneous acute appendicitis and pseudomembranous colitis in a pediatric patient. , 2012, The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society.
[76] Derrick W. Crook,et al. Treatment of First Recurrence of Clostridium difficile Infection: Fidaxomicin Versus Vancomycin , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[77] D. Gerding,et al. Relapse Versus Reinfection: Recurrent Clostridium difficile Infection Following Treatment With Fidaxomicin or Vancomycin , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[78] A. Bustinza,et al. Conservative surgical treatment for toxic megacolon due to Clostridium difficile infection in a transplanted pediatric patient , 2012, Transplant infectious disease : an official journal of the Transplantation Society.
[79] T. Peto,et al. Predictors of First Recurrence of Clostridium difficile Infection: Implications for Initial Management , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[80] M. Falagas,et al. Treatment failure and recurrence of Clostridium difficile infection following treatment with vancomycin or metronidazole: a systematic review of the evidence. , 2012, International journal of antimicrobial agents.
[81] D. Saltzman,et al. Clostridium difficile infection in the pediatric surgery population. , 2012, Journal of pediatric surgery.
[82] E. Videlock,et al. Meta‐analysis: probiotics in antibiotic‐associated diarrhoea , 2012, Alimentary pharmacology & therapeutics.
[83] Susanne Hempel,et al. Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. , 2012, JAMA.
[84] G. Casazza,et al. Saccharomyces boulardii for the Prevention of Antibiotic-Associated Diarrhea in Adult Hospitalized Patients: A Single-Center, Randomized, Double-Blind, Placebo-Controlled Trial , 2012, The American Journal of Gastroenterology.
[85] D. Crook,et al. Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial. , 2012, The Lancet. Infectious diseases.
[86] O. Sigurdardottir,et al. Risk factors for Clostridium difficile toxin-positive diarrhea: a population-based prospective case–control study , 2012, European Journal of Clinical Microbiology & Infectious Diseases.
[87] L. Baddour,et al. Outcomes in community‐acquired Clostridium difficile infection , 2012, Alimentary pharmacology & therapeutics.
[88] S. Coffin,et al. Risk Factors and Outcomes Associated With Severe Clostridium difficile Infection in Children , 2012, The Pediatric infectious disease journal.
[89] M. Jorge,et al. The effect of Lactobacillus casei and Bifidobacterium breve on antibiotic-associated diarrhea treatment: randomized double-blind clinical trial. , 2012, Revista da Sociedade Brasileira de Medicina Tropical.
[90] J. LeLorier,et al. Savings from the use of a probiotic formula in the prophylaxis of antibiotic-associated diarrhea , 2012, Journal of medical economics.
[91] F. Allerberger,et al. Hospital-acquired Clostridium difficile infection: determinants for severe disease , 2011, European Journal of Clinical Microbiology & Infectious Diseases.
[92] B. Cho,et al. Analysis of Clinical Characteristics and Risk Factors to Neurosurgical Patients with Clostridium Difficile-Associated Diarrhea , 2011 .
[93] T. Peto,et al. Molecular Epidemiology of Clostridium difficile Strains in Children Compared with That of Strains Circulating in Adults with Clostridium difficile-Associated Infection , 2011, Journal of Clinical Microbiology.
[94] D. Enoch,et al. Clostridium difficile in children: colonisation and disease. , 2011, The Journal of infection.
[95] Philip M Polgreen,et al. Incidence of and risk factors for community-associated Clostridium difficile infection: A nested case-control study , 2011, BMC infectious diseases.
[96] G. Dumyati,et al. Cumulative antibiotic exposures over time and the risk of Clostridium difficile infection. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[97] C. Gidengil,et al. Epidemiology and Risk Factors for Clostridium difficile Infection in Children , 2011, The Pediatric infectious disease journal.
[98] L. McDonald,et al. Clostridium difficile Infection Among Children With Cancer , 2011, The Pediatric infectious disease journal.
[99] Y. Tabak,et al. Using Electronic Health Information to Risk-Stratify Rates of Clostridium difficile Infection in US Hospitals , 2011, Infection Control & Hospital Epidemiology.
[100] K. Mølbak,et al. Binary Toxin and Death after Clostridium difficile Infection , 2011, Emerging Infectious Diseases.
[101] C. Nylund,et al. Clostridium difficile infection in hospitalized children in the United States. , 2011, Archives of pediatrics & adolescent medicine.
[102] A. Cheng,et al. Australasian Society for Infectious Diseases guidelines for the diagnosis and treatment of Clostridium difficile infection , 2011, The Medical journal of Australia.
[103] S. Fujitani,et al. Comparison of Clinical Severity Score Indices for Clostridium difficile Infection , 2011, Infection Control & Hospital Epidemiology.
[104] J. Kelsen,et al. Recurrence rate of clostridium difficile infection in hospitalized pediatric patients with inflammatory bowel disease , 2011, Inflammatory bowel diseases.
[105] A. Troelstra,et al. Impact of different empirical antibiotic treatment regimens for community-acquired pneumonia on the emergence of Clostridium difficile. , 2010, The Journal of antimicrobial chemotherapy.
[106] T. Casale,et al. Probiotic prophylaxis of ventilator-associated pneumonia: a blinded, randomized, controlled trial. , 2010, American journal of respiratory and critical care medicine.
[107] S. Vindigni,et al. Clostridium difficile Infections among Hospitalized Children, United States, 1997–2006 , 2010, Emerging infectious diseases.
[108] M. Zilberberg. Clostridium difficile Infections among Hospitalized Children , 2010 .
[109] S. Yarlagadda,et al. Epidemiology of community-onset Clostridium difficile infection in a community in the South of England. , 2010, Journal of infection and public health.
[110] L. Shamseer,et al. Measurement Issues in Trials of Pediatric Acute Diarrheal Diseases: A Systematic Review , 2010, Pediatrics.
[111] T. Lamont,et al. Asymptomatic colonization by Clostridium difficile in infants: implications for disease in later life. , 2010, Journal of pediatric gastroenterology and nutrition.
[112] L. Mcfarland. Systematic review and meta-analysis of Saccharomyces boulardii in adult patients. , 2010, World journal of gastroenterology.
[113] C. Donskey,et al. Multihospital Outbreak of Clostridium difficile Infection, Cleveland, Ohio, USA , 2010, Emerging infectious diseases.
[114] A. Bhangu,et al. Mortality and risk stratification in patients with Clostridium difficile‐associated diarrhoea , 2010, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.
[115] S. Wilhelm,et al. Role of Lactobacillus in the Prevention of Antibiotic‐Associated Diarrhea: A Meta‐analysis , 2010, Pharmacotherapy.
[116] Mark A. Miller,et al. Health care-associated Clostridium difficile infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortality. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[117] S. Alam,et al. Antibiotic associated diarrhea in children. , 2009, Indian pediatrics.
[118] R. Chinn,et al. National point prevalence of Clostridium difficile in US health care facility inpatients, 2008. , 2009, American journal of infection control.
[119] M. Hu,et al. Prospective derivation and validation of a clinical prediction rule for recurrent Clostridium difficile infection. , 2009, Gastroenterology.
[120] T. Zaoutis,et al. Presence of the epidemic North American Pulsed Field type 1 Clostridium difficile strain in hospitalized children. , 2009, The Journal of pediatrics.
[121] Mark Miller,et al. Health care-associated Clostridium difficile infection in adults admitted to acute care hospitals in Canada: a Canadian Nosocomial Infection Surveillance Program Study. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[122] B. Limbago,et al. Complete Restriction of Fluoroquinolone Use to Control an Outbreak of Clostridium difficile Infection at a Community Hospital , 2009, Infection Control & Hospital Epidemiology.
[123] Hasse Karlsson. The prevalence of what? , 2009, Nordic journal of psychiatry.
[124] S. Coffin,et al. Epidemiological Features of Clostridium difficile-Associated Disease Among Inpatients at Children's Hospitals in the United States, 2001–2006 , 2008, Pediatrics.
[125] Les Dethlefsen,et al. The Pervasive Effects of an Antibiotic on the Human Gut Microbiota, as Revealed by Deep 16S rRNA Sequencing , 2008, PLoS biology.
[126] L. Mcfarland. Antibiotic-associated diarrhea: epidemiology, trends and treatment. , 2008, Future microbiology.
[127] J. Bartlett,et al. Rising Economic Impact of Clostridium difficile-Associated Disease in Adult Hospitalized Patient Population , 2008, Infection Control & Hospital Epidemiology.
[128] H. Jung,et al. The Effects of Probiotics on PPI‐Triple Therapy for Helicobacter pylori Eradication , 2008, Helicobacter.
[129] G. D'Angelo,et al. Attributable Outcomes of Endemic Clostridium difficile–associated Disease in Nonsurgical Patients , 2008, Emerging infectious diseases.
[130] H. Szajewska,et al. Clinical trial: effectiveness of Lactobacillus rhamnosus (strains E/N, Oxy and Pen) in the prevention of antibiotic‐associated diarrhoea in children , 2008, Alimentary pharmacology & therapeutics.
[131] L. Valiquette,et al. Risk of Clostridium difficile infection after perioperative antibacterial prophylaxis before and during an outbreak of infection due to a hypervirulent strain. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[132] C. Woods,et al. Assessment of Clostridium difficile–Associated Disease Surveillance Definitions, North Carolina, 2005 , 2008, Infection Control & Hospital Epidemiology.
[133] M. Olsen,et al. Short- and long-term attributable costs of Clostridium difficile-associated disease in nonsurgical inpatients. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[134] L. Beaugerie,et al. Effect of Antibiotic Therapy on Human Fecal Microbiota and the Relation to the Development of Clostridium difficile , 2008, Microbial Ecology.
[135] Yan Yan,et al. Clostridium difficile--associated disease in a setting of endemicity: identification of novel risk factors. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[136] B. Heniford,et al. The burden of Clostridium difficile in surgical patients in the United States. , 2007, Surgical infections.
[137] G. Raugi,et al. Fluoroquinolone use and risk factors for Clostridium difficile-associated disease within a Veterans Administration health care system. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[138] M. Beaulieu,et al. Risk of Clostridium difficile-Associated Disease Among Patients Receiving Proton-Pump Inhibitors in a Quebec Medical Intensive Care Unit , 2007, Infection Control & Hospital Epidemiology.
[139] Joseph M. Campos,et al. Changing Epidemiology of Clostridium difficile-Associated Disease in Children , 2007, Infection Control & Hospital Epidemiology.
[140] Melinda B Davis,et al. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[141] M. Hannan,et al. Emergence and Control of Fluoroquinolone-Resistant, Toxin A–Negative, Toxin B–Positive Clostridium difficile , 2007, Infection Control & Hospital Epidemiology.
[142] C. Bulpitt,et al. Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial , 2007, BMJ : British Medical Journal.
[143] D. Gerding,et al. Onset of Symptoms and Time to Diagnosis of Clostridium difficile–Associated Disease Following Discharge From an Acute Care Hospital , 2007, Infection Control & Hospital Epidemiology.
[144] A. van Belkum,et al. Laboratory diagnosis of antibiotic-associated diarrhea: a Polish pilot study into the clinical relevance of Clostridium difficile and Clostridium perfringens toxins. , 2007, Diagnostic microbiology and infectious disease.
[145] Yoram Bloch,et al. Predicting Clostridium difficile Toxin in Hospitalized Patients With Antibiotic-Associated Diarrhea , 2007, Infection Control & Hospital Epidemiology.
[146] N. Ukarapol,et al. Incidence of antibiotic-associated diarrhea in a pediatric ambulatory care setting. , 2007, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.
[147] M. Kollef,et al. Clostridium difficile in the Intensive Care Unit: Epidemiology, Costs, and Colonization Pressure , 2007, Infection Control & Hospital Epidemiology.
[148] Bette Jensen,et al. A hospital outbreak of diarrhea due to an emerging epidemic strain of Clostridium difficile. , 2006, Archives of internal medicine.
[149] C. Langner,et al. Klebsiella oxytoca as a causative organism of antibiotic-associated hemorrhagic colitis. , 2006, The New England journal of medicine.
[150] E. Dubberke. Clostridium difficile -Associated Disease (CDAD) Surveillance: What Definition to Use? , 2006 .
[151] W. Shin,et al. Who are Susceptible to Pseudomembranous Colitis Among Patients with Presumed Antibiotic-Associated Diarrhea? , 2006, Diseases of the colon and rectum.
[152] D. Tompkins,et al. Comparative Analysis of Prevalence, Risk Factors, and Molecular Epidemiology of Antibiotic-Associated Diarrhea Due to Clostridium difficile, Clostridium perfringens, and Staphylococcus aureus , 2006, Journal of Clinical Microbiology.
[153] Shan-Chwen Chang,et al. Prevalence and clinical features of Clostridium difficile-associated diarrhea in a tertiary hospital in northern Taiwan. , 2006, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.
[154] B. Beşirbellioğlu,et al. Prophylactic Saccharomyces boulardii in the prevention of antibiotic-associated diarrhea: a prospective study. , 2006, Medical science monitor : international medical journal of experimental and clinical research.
[155] S. Clark,et al. The outcome of surgery in fulminant Clostridium difficile colitis , 2006, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.
[156] Ken Dewar,et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. , 2005, The New England journal of medicine.
[157] M. Kulkarni,et al. Diagnostic role of stool culture & toxin detection in antibiotic associated diarrhoea due to Clostridium difficile in children. , 2005, The Indian journal of medical research.
[158] D. Oğuz,et al. Efficacy and safety of Saccharomyces boulardii in prevention of antibiotic-associated diarrhoea due to Helicobacterpylori eradication , 2005, European journal of gastroenterology & hepatology.
[159] V. Morinville,et al. Clostridium difficile-associated diarrhea in 200 Canadian children. , 2005, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.
[160] J. Nicoli,et al. A Randomized Formula Controlled Trial of Bifidobacterium lactis and Streptococcus thermophilus for Prevention of Antibiotic-Associated Diarrhea in Infants , 2005, Journal of clinical gastroenterology.
[161] T. Karasawa,et al. Colonization by Clostridium difficile of neonates in a hospital, and infants and children in three day-care facilities of Kanazawa, Japan. , 2005, International microbiology : the official journal of the Spanish Society for Microbiology.
[162] Carlene A. Muto,et al. A Large Outbreak of Clostridium difficile–Associated Disease with an Unexpected Proportion of Deaths and Colectomies at a Teaching Hospital Following Increased Fluoroquinolone Use , 2005, Infection Control & Hospital Epidemiology.
[163] H. Szajewska,et al. Saccharomyces boulardii in the prevention of antibiotic‐associated diarrhoea in children: a randomized double‐blind placebo‐controlled trial , 2005, Alimentary pharmacology & therapeutics.
[164] J. Penders,et al. Quantification of Bifidobacterium spp., Escherichia coli and Clostridium difficile in faecal samples of breast-fed and formula-fed infants by real-time PCR. , 2005, FEMS microbiology letters.
[165] A. Rodloff,et al. Prevalence and characteristics of bacteria and host factors in an outbreak situation of antibiotic-associated diarrhoea. , 2005, Journal of medical microbiology.
[166] A. Yuce,et al. Antibiotic-Associated Diarrhea in a Turkish Outpatient Population: Investigation of 288 Cases , 2005, Journal of chemotherapy.
[167] J. Mazuski,et al. Outcome After Colectomy for Clostridium Difficile Colitis , 2004, Diseases of the colon and rectum.
[168] Louis Valiquette,et al. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity , 2004, Canadian Medical Association Journal.
[169] I. Odenholt,et al. A double-blind randomized controlled trial of fusidic acid and metronidazole for treatment of an initial episode of Clostridium difficile-associated diarrhoea. , 2004, The Journal of antimicrobial chemotherapy.
[170] R. Gaynes,et al. Outbreak of Clostridium difficile infection in a long-term care facility: association with gatifloxacin use. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[171] T. Schmidt,et al. Antibiotic-Associated Diarrhea Accompanied by Large-Scale Alterations in the Composition of the Fecal Microbiota , 2004, Journal of Clinical Microbiology.
[172] G. Bottaro,et al. [Prevention of antibiotic-associated diarrhea with Lactobacillus sporogens and fructo-oligosaccharides in children. A multicentric double-blind vs placebo study]. , 2003, Minerva pediatrica.
[173] F. Gottrand,et al. Incidence and Risk Factors of Oral Antibiotic‐Associated Diarrhea in an Outpatient Pediatric Population , 2003, Journal of pediatric gastroenterology and nutrition.
[174] A. Komiyama,et al. Prevention of antibiotic‐associated diarrhea in children by Clostridium butyricum MIYAIRI , 2003, Pediatrics international : official journal of the Japan Pediatric Society.
[175] I. Odenholt,et al. Lactobacillus plantarum 299v for the Treatment of Recurrent Clostridium difficile-associated Diarrhoea: A Double-blind, Placebo-controlled Trial , 2003, Scandinavian journal of infectious diseases.
[176] R. Wongarn,et al. Prevention of antibiotic-associated diarrhea in infants by probiotics. , 2002, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.
[177] Lynne V McFarland,et al. Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease , 2002, American Journal of Gastroenterology.
[178] C. Sirio,et al. Fulminant Clostridium difficile: An Underappreciated and Increasing Cause of Death and Complications , 2002, Annals of surgery.
[179] J. Bartlett,et al. A NTIBIOTIC -A SSOCIATED D IARRHEA , 2002 .
[180] C. Surawicz,et al. The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[181] S. Guandalini,et al. Pediatric Clostridium difficile: A Phantom Menace or Clinical Reality? , 2000, Journal of pediatric gastroenterology and nutrition.
[182] F. Barbut,et al. Epidemiology of Recurrences or Reinfections ofClostridium difficile-Associated Diarrhea , 2000, Journal of Clinical Microbiology.
[183] M. Siemann,et al. Clostridium difficile-associated diseases , 2000, Intensive Care Medicine.
[184] M. Samore,et al. Epidemics of diarrhea caused by a clindamycin-resistant strain of Clostridium difficile in four hospitals. , 1999, The New England journal of medicine.
[185] L. Maunula,et al. Prophylactic Lactobacillus GGReduces Antibiotic-Associated Diarrhea in Children With Respiratory Infections: A Randomized Study , 1999, Pediatrics.
[186] J. Vanderhoof,et al. Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children. , 1999, The Journal of pediatrics.
[187] C. Surawicz,et al. Possible role of cross-transmission between neonates and mothers with recurrent Clostridium difficile infections. , 1999, American journal of infection control.
[188] T. Crabtree,et al. Clinical characteristics and antibiotic utilization in surgical patients with Clostridium difficile-associated diarrhea. , 1999, The American surgeon.
[189] D. O'neill,et al. Factors associated with prolonged symptoms and severe disease due to Clostridium difficile. , 1999, Age and ageing.
[190] C. Surawicz,et al. Recurrent Clostridium Difficile Disease: Epidemiology and Clinical Characteristics , 1999, Infection Control & Hospital Epidemiology.
[191] McFarland Lv. Facteurs de risque de la diarrhée associée aux antibiotiques : Une revue de la littérature , 1998 .
[192] P. Berche,et al. Nosocomial outbreak ofClostridium difficile diarrhea in a pediatric service , 1997, European Journal of Clinical Microbiology and Infectious Diseases.
[193] R. Rogers,et al. Clostridium difficile Infection in Obstetric and Gynecologic Patients , 1997, Southern medical journal.
[194] L. Pickering,et al. Prospective study of toxigenic Clostridium difficile in children given amoxicillin/clavulanate for otitis media. , 1996, The Pediatric infectious disease journal.
[195] W. Graninger,et al. Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile-associated diarrhea. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[196] C. Surawicz,et al. Ciprofloxacin-associated Clostridium difficile disease , 1995, The Lancet.
[197] L. Bodenstein,et al. SevereClostridium difficile colitis , 1995, Diseases of the colon and rectum.
[198] S. Beekmann,et al. PCR amplification of rRNA intergenic spacer regions as a method for epidemiologic typing of Clostridium difficile , 1995, Journal of clinical microbiology.
[199] C. Surawicz,et al. A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. , 1994, JAMA.
[200] W. Stamm,et al. Correlation of immunoblot type, enterotoxin production, and cytotoxin production with clinical manifestations of Clostridium difficile infection in a cohort of hospitalized patients , 1991, Infection and immunity.
[201] S. Hamilton,et al. Clostridium difficile invasion and toxin circulation in fatal pediatric pseudomembranous colitis. , 1990, American journal of clinical pathology.
[202] C. Surawicz,et al. Risk factors for Clostridium difficile carriage and C. difficile-associated diarrhea in a cohort of hospitalized patients. , 1990, The Journal of infectious diseases.
[203] W. Stamm,et al. Nosocomial acquisition of Clostridium difficile infection , 1990 .
[204] C. Surawicz,et al. Treatment of recurrent Clostridium difficile colitis with vancomycin and Saccharomyces boulardii. , 1989, The American journal of gastroenterology.
[205] G. Belle,et al. Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective study. , 1989, Gastroenterology.
[206] P. Krause,et al. Occurrence of Clostridium difficile toxin-associated gastroenteritis following antibiotic therapy for otitis media in young children. , 1984, Pediatric infectious disease.
[207] Y. Benno,et al. The Intestinal Microflora of Infants: Composition of Fecal Flora in Breast‐Fed and Bottle‐Fed Infants , 1984, Microbiology and immunology.
[208] H. Dupont,et al. Outbreaks of diarrhea associated with Clostridium difficile and its toxin in day-care centers: evidence of person-to-person spread. , 1983, The Journal of pediatrics.
[209] R. Roberts,et al. Relapse of antibiotic associated colitis: endogenous persistence of Clostridium difficile during vancomycin therapy. , 1983, Gut.
[210] G. Fleisher,et al. Clostridium difficile in a pediatric outpatient population , 1982, Pediatric infectious disease.
[211] B. Devine,et al. Gastrointestinal side effects of clindamycin and ampicillin therapy. , 1977, The Journal of infectious diseases.
[212] E. McDonald,et al. Clostridium difficile Infection. , 2015, The New England journal of medicine.
[213] L. Schroeder,et al. Burden of Clostridium difficile infection in the United States. , 2015, The New England journal of medicine.
[214] Eur J Clin. Clostridium difficile infection in children hospitalized due to diarrhea , 2014 .
[215] S. Lehrer. Duodenal infusion of feces for recurrent Clostridium difficile. , 2013, The New England journal of medicine.
[216] Duolao Wang,et al. A high-dose preparation of lactobacilli and bifidobacteria in the prevention of antibiotic-associated and Clostridium difficile diarrhoea in older people admitted to hospital: a multicentre, randomised, double-blind, placebo-controlled, parallel arm trial (PLACIDE). , 2013, Health technology assessment.
[217] T. V. Van Schooneveld,et al. Duodenal infusion of feces for recurrent Clostridium difficile. , 2013, The New England journal of medicine.
[218] 郭俊男. Probiotics for the Prevention of Clostridium difficle- Associated Diarrhea: A Systematic Review and Meta-analysisi , 2013 .
[219] A. Zinsmeister,et al. Corrigendum: The Epidemiology of Community-Acquired Clostridium difficile Infection: A Population-Based Study , 2012, The American Journal of Gastroenterology.
[220] J. Stockman. Treatment with Monoclonal Antibodies against Clostridium difficile Toxins , 2011 .
[221] Guang-xi Li,et al. Clinical practice guidelines for Clostridium difficile infection in adults:2010 update by the Society for Healthcare Epidemiology of America(SHEA)and the Infectious Diseases Society of America(IDSA) , 2011 .
[222] Aseem Kumar,et al. Fulminant Clostridium difficile Colitis: Patterns of Care and Predictors of Mortality , 2010 .
[223] M. Delmée,et al. Clostridium difficile in neonates: serogrouping and epidemiology , 2004, European Journal of Pediatrics.
[224] C. Nord,et al. Frequency of antibiotic-associated diarrhoea in 2462 antibiotic-treated hospitalized patients: a prospective study. , 2001, The Journal of antimicrobial chemotherapy.
[225] A. Stergachis,et al. Antibiotics and Clostridium difficile diarrhea in the ambulatory care setting. , 2000, Clinical therapeutics.
[226] P. Mangell,et al. LACTOBACILLUS PLANTARUM 299V INHIBITS ESCHERICHIA COLI-INDUCED , 2000 .
[227] E. Kerem,et al. Severe Clostridium difficile-associated colitis in young patients with cystic fibrosis. , 1998, The Journal of pediatrics.
[228] R. Platt,et al. Epidemiology of community-acquired Clostridium difficile-associated diarrhea. , 1994, The Journal of infectious diseases.
[229] Binary toxin , 1984, Nature.